🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to assess the safety of a potential new drug DU-176b for the ...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00504556
Treatments Being Tested
The overall aim of this research is to improve secondary stroke prevention ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07454707
Treatments Being Tested
This is an event driven Phase 3, prospective, randomized, open-label, blind...
Status
Completed
Location
Banner University Medical Center
Start Date
2017-03-27
Trial ID
NCT02798471
Treatments Being Tested
The objective of this study is to assess the efficacy, safety and dose-resp...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT01203072
Based on the population pharmacokinetic data of Chinese patients with atria...
Status
Completed
Location
Fuwai Hospital, Chinese Academy of Medical Sciences
Start Date
2022-03-30
Trial ID
NCT05320627
Treatments Being Tested
The primary objective is to demonstrate the non-inferiority of edoxaban (pr...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-16
Trial ID
NCT02073682
Treatments Being Tested
This study aims to evaluate the effects of combination therapy of tegopraza...
Status
Completed
Location
Jeonbuk National University Hospital
Start Date
2023-03-06
Trial ID
NCT05723510
Treatments Being Tested
There is emerging evidence that patients with SARS-CoV-2 are affected by in...
Status
Terminated
Location
Jessa Ziekenhuis
Start Date
2021-01-21
Trial ID
NCT04516941
Treatments Being Tested
This Phase 1 study consists of 2 parts. Part 1 will be an open-label, rando...
Status
Completed
Location
Quintiles
Start Date
2013-10
Trial ID
NCT02047565
Treatments Being Tested
A committee will judge the safety and effectiveness of edoxaban and the reg...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-05-15
Trial ID
NCT03395639
Treatments Being Tested